We are live on ! Find out more
EBACU

European Biotech Acquisition Corp. Units
EBACU

Delisted

EBACU was delisted on the 2nd of March, 2023.

Back to rankings

37 hedge funds and large institutions have $41.2M invested in European Biotech Acquisition Corp. Units in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

39% less funds holding

Funds holding: 61 → 37 (-24)

54% less capital invested

Capital invested by funds: $89.3M → $41.2M (-$48.1M)

83% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 29

Holders
37
Holders Change
-24
Holders Change %
-39.34%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
12
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
+$2.1M
2
PC
Periscope Capital
Ontario, Canada
+$1.15M
3
MTCM
Mint Tower Capital Management
Netherlands
+$701K
4
WC
Wealthspring Capital
New York
+$370K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$354K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$6.28M
2
LA
Linden Advisors
New York
-$5.01M
3
Marshall Wace
Marshall Wace
United Kingdom
-$3.27M
4
SCM
Suvretta Capital Management
New York
-$3.02M
5
SSA
Schonfeld Strategic Advisors
New York
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
51
Tenor Capital Management
New York
– -$1.01M -100,000 Closed
DCM
52
Dupont Capital Management
Delaware
– -$1M -99,996 -100%
EAM
53
Exos Asset Management
New York
– -$502K -50,000 Closed
SCC
54
Spring Creek Capital
Kansas
– -$503K -50,000 Closed
WA
55
Whitebox Advisors
Minnesota
– -$503K -50,000 Closed
AA
56
AQR Arbitrage
Connecticut
– -$442K -44,000 Closed
ACM
57
Atalaya Capital Management
New York
– -$402K -40,000 Closed
CC
58
Centiva Capital
New York
– -$402K -40,000 Closed
OAC
59
OMERS Administration Corp
Ontario, Canada
– -$352K -35,000 Closed
VI
60
Vestcor Inc
New Brunswick, Canada
– -$352K -35,000 Closed
MP
61
Mangrove Partners
Connecticut
– -$201K -20,000 Closed
WRBC
62
W.R. Berkley Corp
Connecticut
– -$198K -19,650 Closed
Voloridge Investment Management
63
Voloridge Investment Management
Florida
– -$154K -15,329 Closed
PCM
64
Prelude Capital Management
New York
– -$101K -10,000 Closed
AA
65
Ancora Advisors
Ohio
– -$70K -7,000 Closed
Toronto Dominion Bank
66
Toronto Dominion Bank
Ontario, Canada
– -$8K -800 Closed
1 2
3

EBACU Hedge Fund Activity: Q2 2021 in Review

37 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q2 2021, worth a combined $41.2M — down 54% from $89.3M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of EBACU and 5 opened new positions — a net loss of 24 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was First Trust Capital Management, opening a new position worth an estimated $2.1M. The largest seller was Citadel Advisors, exiting entirely with an estimated $6.28M sold.

  • 37 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q2 2021, down from 61 in Q1 2021.
  • Funds reported $41.2M of European Biotech Acquisition Corp. Units stock for Q2 2021, down 54% quarter-over-quarter.
  • 5 funds opened new European Biotech Acquisition Corp. Units positions in Q2 2021 and 29 closed out, a net change of -24 holders.
  • The largest European Biotech Acquisition Corp. Units buyer in Q2 2021 was First Trust Capital Management, an estimated $2.1M added.
  • The largest European Biotech Acquisition Corp. Units seller in Q2 2021 was Citadel Advisors, an estimated $6.28M sold.

Based on aggregated 13F filings for Q2 2021.